Persistent Papilledema in Ulirich-Turner Syndrome Treated with Growth Hormone

Abstract

Get full access to this article

View all access options for this article.

References

1. Menkes JH . Pseudotumor cerebri (iiopathic intracranial hypertension). In: Textbook of Child Neurology, 3d ed. Philadelphia: Lea & Febiger; 1985; pp 580-581.

2. Babikian P , Corbett J , Bell W . Idipathic intracranial hypertension in children: the Iowa experience. J Child Neurol. 1994;9:144-149.

3. Trauner DA . Increased intracranial pressure. In: Swaiman KF , Ashwal S (eds): Paediatric Neurology Principles and Practise, vol 1, 2d ed. St Louis: Mosby; 1994 pp 202-203.

4. Soler D , Cox T , Bullock P , Calver DM , et al. Diagnosis and management of benign intracranial hypertension. Arch Dis Child. 1998;78:89-94.

5. Allen DB . Safety of human growth hormone therapy: current topics.J Pdiatr; 1996;128:8-13.

6. Blethen SL , Allen DB , Graves D , et al. Safety of recombinant desoxyriboncleic acid derived growth hormone: the National Co-operative Growth Study. J Clin Endorinol Metab. 1996;81:1704-1710.

7. Francois I , Casteels I , Silberstein J , Casaer P , et al. Empty sella, growth hormone deficiency and pseudotmor cerebri: effect of initiation, witdrawal and resumption of growth homone therapy. Eur J Pediatr. 1997;156: 69-70.

8. Malozowski S , Tanner LA , Wysowski DK , et al. Growth hormone, insulilike growth factor 1, and benign itracranial hypertension. NEngl J Med. 1993;329:665-666.

9. Rahm V , Wilton P , Collins R . Benign intracranial hypertension is a rare event in risk patients treated with growth hormone. Horm Res. 1995;47: 91-91.

10.

10. Crock PA , McKenzie J , Nicoll A , et al. Benign intracranial hypertension and recombinant growth hormone theapy in Australia and New Zealand. Acta Paediatr 1998;87:381-386.